BPA Call HT001420A0020-HT009025FG0410058
Award Date 4/2/25
Potential Completion Date 9/30/25
Potential Value $22K
Federal Agency
Ultimate Awardee
Not listed NAICS Category
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Competed under SAP
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Princeton, NJ, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This federal contract award to Sun Pharmaceutical Industries, Inc. by the Defense Health Agency is for the provision of nuclear medicine imaging products. The $986,924.50 firm-fixed-price purchase order covers the supply of medical imaging products for myocardial infarct imaging, diagnostic imaging of gallbladder disorders, and breast cancer nodule imaging. The contract has an ultimate completion date of March 11, 2026. This award is associated with Sun Pharmaceutical's existing Federal Supply...
- This is a firm fixed-price blanket purchase agreement (BPA) call contract awarded by the Defense Health Agency (DHA), a component of the Department of Defense, to Pharmalucence, Inc., a specialty pharmaceutical manufacturer. The contract is for the provision of radiopharmaceuticals and related supplies to support nuclear medicine diagnostic services at military treatment facilities. The total ceiling value of the contract is $40,878.40, and it has an ultimate completion date of September 30,...
- This is a firm fixed price blanket purchase agreement (BPA) call contract awarded by the Defense Health Agency (DHA) to Pharmalucence, Inc. for the supply of radiopharmaceuticals and related products. The contract has a ceiling value of $75,000.00 and a period of performance through September 30, 2024. Pharmalucence, Inc. is a specialty pharmaceutical company focused on manufacturing and distributing generic radiopharmaceutical products and supplies. The DHA, a component of the Department of...
- This is a firm fixed price blanket purchase agreement (BPA) call contract awarded by the Defense Health Agency (DHA), a component of the Department of Defense, to Pharmalucence, Inc., a specialty pharmaceutical company focused on manufacturing and distributing generic radiopharmaceutical products and supplies. The contract, worth up to $80,000.00, is for the delivery of various radiopharmaceuticals to military treatment facilities to support nuclear medicine diagnostic services for active duty...
- This is a firm fixed price purchase order awarded by the Defense Health Agency (DHA), a component of the Department of Defense, to Pharmalucence, Inc., a specialty pharmaceutical company. The contract is for the delivery of SC05 SULFUR COLLOID 5VIALS/BX, a radiopharmaceutical product, with a ceiling value of $87,105.00 and a period of performance through December 31, 2015. Pharmalucence, Inc. has been awarded multiple federal contracts and task orders by the DHA and Department of the Navy Bureau...
- This contract was awarded by the Defense Health Agency (DHA) to Pharmalucence, Inc., a specialty pharmaceutical manufacturer, to provide radiopharmaceuticals and supplies. The contract is a firm fixed price blanket purchase agreement (BPA) call with a potential value of $25,000.00 and a completion date of September 30, 2023. The products will be delivered to facilities in El Paso, Texas to support nuclear medicine diagnostic services for the Military Health System's 9.5 million beneficiaries....
- This firm fixed-price purchase order for $124,815.00 was awarded by the Defense Health Agency (DHA) to Pharmalucence, Inc., a specialty pharmaceutical company focused on manufacturing and distributing generic radiopharmaceutical products and supplies. The contract is for the delivery of SC05 Sulfur Colloid 5 vials/box to support nuclear medicine diagnostic services for active duty personnel and their families within the Military Health System. Pharmalucence, Inc. has been awarded multiple...
- This federal contract award is for the provision of radiopharmaceuticals to the Defense Health Agency (DHA), a defense agency. The contract was awarded to Cardinal Health 414, LLC, a subsidiary of the global healthcare services company Cardinal Health, Inc. The contract has a ceiling value of $563,789.91 and a period of performance ending on September 30, 2026. It is a firm fixed-price delivery order contract, without any set-aside designation. Cardinal Health 414, LLC is a prominent supplier of...
- This contract was awarded by the Defense Health Agency (DHA) to Jubilant Draximage Radiopharmacies, Inc., doing business as Jubilant Radiopharma, for the provision of radiopharmaceuticals. The contract has a firm fixed price and is valued at $200,000.00. The period of performance runs from October 1, 2019 to September 30, 2021. Jubilant Radiopharma is a self-certified small disadvantaged business that has received multiple awards from the Department of Veterans Affairs (VA) and DHA totaling over...
- This is a firm-fixed-price delivery order contract awarded to Jubilant Draximage Radiopharmacies, Inc. (doing business as Jubilant Radiopharma), a for-profit small disadvantaged business, by the U.S. Department of Veterans Affairs (VA) for the supply of radiopharmaceuticals. The contract has a total ceiling value of $514,985.56 and a completion date of March 4, 2026. Jubilant Radiopharma is a subsidiary of Jubilant Life Sciences Limited and specializes in the manufacturing, distribution, and...